• ISRIB (trans-isomer) for ISR Memory Research

  2026-08-25

  ISRIB (trans-isomer) connects mechanistic ER stress experiments with inflammation-associated memory research by restoring translation downstream of eIF2α phosphorylation. This guide outlines cell-based validation, recognition-memory workflows, assay controls, and troubleshooting strategies for using this PERK inhibitor without overinterpreting behavioral effects.

• Mianserin HCl: Workflow for 5-HT2 Studies

  2026-08-24

  Mianserin HCl supports receptor pharmacology, neuronal phenotyping, cyclodextrin-enabled cytotoxicity studies, and exploratory antipathogenic workflows. This practical guide translates placebo-controlled evidence into assay design, formulation choices, controls, and troubleshooting strategies.

• DMH1: A Tunable Lever for BMP Translation

  2026-08-24

  A translational perspective on DMH1 as a selective ALK2 inhibitor for connecting organoid cell-fate control with mechanistic non-small cell lung cancer research.

• AI-10-49 in CBFβ-SMMHC Leukemia Research

  2026-08-23

  AI-10-49 enables a mechanism-first workflow for studying inv(16) leukemia: disrupt the CBFβ-SMMHC–RUNX1 interaction, measure restored transcriptional activity, and connect those changes to survival phenotypes. Its submicromolar activity and reported in vivo benchmark make it useful for coordinated cellular, chromatin, and animal-model experiments.

• Berberine hydrochloride: Gut–Bone Axis Workflows

  2026-08-22

  Translate berberine hydrochloride’s AMPK and gut–bone axis biology into reproducible cell, organoid, barrier, and osteoimmune assays. This guide emphasizes salt-aware controls, solvent handling, tuft-cell readouts, and troubleshooting rather than unvalidated therapeutic claims.

• Reversine: Aurora Kinase Inhibitor Workflows

  2026-08-22

  Reversine enables integrated studies of Aurora kinase signaling, mitotic checkpoint control, proliferation, and apoptosis. This guide translates its reported biochemical potency into practical dose-response, imaging, cervical cancer, and MCC-disassembly workflows with troubleshooting guidance.

• ROS-Responsive LNPs for Mutant RAS mRNA Delivery

  2026-08-21

  The reference study developed a combinatorial library of thioketal-containing, ROS-degradable lipid nanoparticles and identified BAmP-TK-12 as a preferential mRNA carrier for tumor cells. Delivery of DUF5-encoding mRNA enabled cleavage of mutant RAS and produced stronger antitumor activity than a small-molecule RAS inhibitor in the reported experimental models.

• Moxifloxacin: From Gyrase to Cell Phenotypes

  2026-08-20

  Moxifloxacin is a fluoroquinolone antibiotic that connects bacterial DNA gyrase inhibition with measurable cellular and metabolic phenotypes. This article shows how structural insight from gyrase research can guide antibiotic toxicity research, assay selection, and interpretation of mammalian responses.

• Validated HPLC for Trelagliptin Succinate Impurities

  2026-08-20

  The reference study developed and validated a stability-indicating HPLC method that separates trelagliptin succinate from eight potential process-related impurities and stress-generated degradation products. Its combination of chromatographic validation, forced-degradation testing, and UHPLC–Orbitrap mass spectrometry provides a practical framework for quality control in dosage-form development.

• Ertugliflozin (PF-04971729) Research Workflows

  2026-08-19

  Build reproducible renal transport, metabolic, and brain insulin-signaling experiments with the highly selective SGLT2 inhibitor PF-04971729. This workflow-focused guide connects glucose reabsorption inhibition with translational Alzheimer’s disease research while emphasizing compound handling, assay controls, and troubleshooting.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-08-19

  Breen and colleagues developed a genetically drug-sensitized yeast platform that detects TOR/mTOR pathway inhibitors at substantially lower concentrations than conventional wild-type yeast assays. The system distinguished known TOR inhibitors, identified aminophylline as a TOR1-dependent growth inhibitor, and found no evidence of TOR inhibition by Canagliflozin under the tested conditions.

• Artesunate Workflows for Cancer Cell Death

  2026-08-18

  Artesunate enables cancer researchers to distinguish growth inhibition from true cell killing while probing ferroptosis, pyroptosis-related signaling, and AKT/mTOR responses. This practical guide covers stock preparation, time-resolved assays, model selection, and troubleshooting for small cell lung carcinoma and esophageal squamous cell carcinoma studies.

• Berberine Hydrochloride in Gut–Bone Assays

  2026-08-18

  Build reproducible berberine hydrochloride workflows for gut–bone, metabolic, microbiome, and cell-death research. This guide translates a tuft-cell study into practical assay choices while addressing solubility, salt-form comparisons, controls, and readout optimization.

• Ganetespib (STA-9090) Research Workflow Guide

  2026-08-17

  Ganetespib (STA-9090) combines nanomolar Hsp90 inhibition with a practical workflow for studying client-protein loss, cancer-cell viability, and tumor growth inhibition. This guide translates its triazolone chemistry into reproducible assay design while using a norovirus secretion study to sharpen compartment-specific readouts.

• Cy5 Hydrazide for Carbonyl Labeling in Nanotech

  2026-08-17

  Cy5 hydrazide converts otherwise difficult-to-measure aldehyde and ketone modifications into a far-red fluorescence signal for protein carbonylation labeling, glycoprotein analysis, and nanoparticle-interface studies. Its strong optical response and SDS-PAGE compatibility are balanced by a practical requirement: prepare the non-sulfonated dye in an organic co-solvent and remove unreacted material before quantification.

8595 records 2/573 page Previous Next 12345 下5页 Last page